These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31649334)

  • 1. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
    Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
    Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
    PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic ARC protein confers chemoresistance by controlling leukemia-microenvironment interactions through a NFκB/IL1β signaling network.
    Carter BZ; Mak PY; Chen Y; Mak DH; Mu H; Jacamo R; Ruvolo V; Arold ST; Ladbury JE; Burks JK; Kornblau S; Andreeff M
    Oncotarget; 2016 Apr; 7(15):20054-67. PubMed ID: 26956049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
    Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
    Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
    Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
    PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
    Okamoto S; Miyano K; Kitakaze K; Kato H; Yamauchi A; Kajikawa M; Itsumi M; Kawai C; Kuribayashi F
    Biochem Biophys Res Commun; 2022 Jan; 587():78-84. PubMed ID: 34872003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.
    Griessinger E; Anjos-Afonso F; Pizzitola I; Rouault-Pierre K; Vargaftig J; Taussig D; Gribben J; Lassailly F; Bonnet D
    Stem Cells Transl Med; 2014 Apr; 3(4):520-9. PubMed ID: 24493855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.
    Mak PY; Mak DH; Mu H; Shi Y; Ruvolo P; Ruvolo V; Jacamo R; Burks JK; Wei W; Huang X; Kornblau SM; Andreeff M; Carter BZ
    Apoptosis; 2014 Apr; 19(4):698-707. PubMed ID: 24337870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia.
    Piya S; Andreeff M; Borthakur G
    Autophagy; 2017 Jan; 13(1):214-215. PubMed ID: 27797294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
    Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
    J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.
    Hosseini M; Rezvani HR; Aroua N; Bosc C; Farge T; Saland E; Guyonnet-Dupérat V; Zaghdoudi S; Jarrou L; Larrue C; Sabatier M; Mouchel PL; Gotanègre M; Piechaczyk M; Bossis G; Récher C; Sarry JE
    Cancer Res; 2019 Oct; 79(20):5191-5203. PubMed ID: 31358527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gap Junctions in the Bone Marrow Lympho-Hematopoietic Stem Cell Niche, Leukemia Progression, and Chemoresistance.
    Singh AK; Cancelas JA
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991829
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cx25 contributes to leukemia cell communication and chemosensitivity.
    Sinyuk M; Alvarado AG; Nesmiyanov P; Shaw J; Mulkearns-Hubert EE; Eurich JT; Hale JS; Bogdanova A; Hitomi M; Maciejewski J; Huang AY; Saunthararajah Y; Lathia JD
    Oncotarget; 2015 Oct; 6(31):31508-21. PubMed ID: 26375552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
    Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
    Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.
    Cai H; Kondo M; Sandhow L; Xiao P; Johansson AS; Sasaki T; Zawacka-Pankau J; Tryggvason K; Ungerstedt J; Walfridsson J; Ekblom M; Qian H
    Blood; 2022 May; 139(20):3040-3057. PubMed ID: 34958665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.